Evidence map›Paper›PMID 21979892›Full record

ArticleJournal of neuro-oncology2012

Expression of dual angiogenic/neurogenic growth factors in human primary brain tumors.

Maud Clemessy, Robert C Janzer, Benoìt Lhermitte, Jean-Marie Gasc, Lucienne Juillerat-Jeanneret

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maud ClemessyINSERM U833, Collège-de-France, 11 place Marcelin Berthelot, Paris, France.
Robert C Janzer
Benoìt Lhermitte
Jean-Marie Gasc
Lucienne Juillerat-Jeanneret
University Hospital of Lausanne · CHInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumors, benign or malignant, are characterized by a very high degree of vascularization. Recent accumulating evidence suggests that during development the neuronal wiring follows the same routes as the vasculature and that these two systems may share some of the same factors for guidance. Thus, expression of dual angiogenic/neurogenic growth factors was evaluated by in situ hybridization in human primary brain tumors of three different types, i.e., astrocytomas, oligodendrogliomas, and ependymomas, of increasing grades, in relation with the grade and type of the tumor. For this evaluation we selected vascular endothelial growth factor (VEGF-A) and its receptors VEGF-R1 and VEGF-R2 and the neuropilins 1 and 2 (NRP-1 and NRP-2), which have proangiogenic properties, platelet-derived growth factor (PDGF) receptor-beta (PDGF-Rβ), which is required for the functional maturation of blood vessels, the ephrins and their Eph receptors, angiotensinogen (AGT) and thrombospondin-2 (TSP-2), which have potential antiangiogenic properties, and netrin-1 (Net-1), which regulates vascular architecture. We show that the expression of the VEGF-NRP system, PDGF-Rβ, TSP-2, AGT, and Net-1 are differentially regulated, either increased or decreased, in relation with the type and grade of the tumor, whereas regulation of the ephrinB system does not seem to be relevant in these human brain tumors.

Indexed as

Angiogenic ProteinsAngiotensinogenBrain NeoplasmsHumansIn Situ HybridizationIntercellular Signaling Peptides and ProteinsNeoplasm GradingNeuropilin-1Neuropilin-2Oncogene ProteinsReceptor, Platelet-Derived Growth Factor betaRetrospective StudiesRNA, MessengerRNA ProbesThrombospondin 2ThrombospondinsAGT protein, humanAngiogenic ProteinsAngiotensinogenIntercellular Signaling Peptides and ProteinsNET1 protein, humanNeuropilin-1Neuropilin-2Oncogene ProteinsReceptor, Platelet-Derived Growth Factor betaRNA, MessengerRNA ProbesThrombospondin 2ThrombospondinsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2VEGFA protein, human

Identifiers

PMID21979892
OpenAlexW1995587804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.